まとめ
子宮中のエクスタシー (MDMA) 曝露は,新生児の先天性欠陥のリスクを増やす可能性があります. この前向きな研究では,暴露された乳児の心臓血管および筋骨格の異常率が高かったことが判明しました.
科学分野:
- 産周医学は,産周医学である.
- 発達毒理学 発達毒理学
- 産科は産婦人科です.
背景:
- 娯楽用薬物使用が胎児の発達に及ぼす子宮内効果を調査することは,潜在的な健康リスクを理解するために不可欠です.
- エクスタシー (3,4-メチレンディオキシメタンフェタミン) は,未知の長期的な発達効果を持つ,広く使用されているレクリエーション用薬物です.
- この研究では,妊娠中にエクスタシーに曝された乳児を前向きに追跡した.
さらに関連する動画
15:27Construction of Vapor Chambers Used to Expose Mice to Alcohol During the Equivalent of all Three Trimesters of Human Development
Published on: July 13, 2014
07:36Modeling Encephalopathy of Prematurity Using Prenatal Hypoxia-ischemia with Intra-amniotic Lipopolysaccharide in Rats
Published on: November 20, 2015
関連する概念動画
01:07Teratogenicity
The ability of a drug to produce structural deformations and functional abnormalities in the developing embryo or the fetus is called teratogenicity, and the drug producing this effect is known as a teratogen. Teratogenic effects include stillbirth, miscarriage, intrauterine growth restriction, and neurocognitive delay. A teratogen may affect the embryo at different stages of development, which is important in determining the type and extent of the damage. During blastocyst formation, the early...
01:24Drug Toxicity: Risk factors
Adverse Drug Reactions (ADRs) are potential complications that arise during pharmacotherapy, influenced by multiple risk factors. Age plays a significant role; both neonates and the elderly are at heightened risk due to their respective immature and diminished metabolic and elimination processes. Gender also impacts ADRs, with females experiencing a 1.5 to 1.7-fold greater risk than males, which may be linked to pharmacokinetic, pharmacodynamic, and hormonal differences. Notably, neonates, the...